HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-farnesyl-norcantharimide

has antineoplastic activity; structure in first source

Also Known As:

NC15 compound

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzofurans: 26
      - Cantharidin: 597
        N-farnesyl-norcantharimide: 2

Experts

1.	Chen, Yu-Jen: 2 articles (05/2020 - 06/2015)
2.	Kuo, Cheng-Deng: 2 articles (05/2020 - 06/2015)
3.	Liao, Hui-Fen: 2 articles (05/2020 - 06/2015)
4.	Tsai, En-Tung: 2 articles (05/2020 - 06/2015)
5.	Wu, Jin-Yi: 2 articles (05/2020 - 06/2015)
6.	Lin, Jui-Feng: 1 article (05/2020)
7.	Yang, Fang-Yu: 1 article (05/2020)
8.	Chang, Ming-Che: 1 article (06/2015)

Related Diseases

1.	Leukemia 06/01/2015 - "N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model." 06/01/2015 - "This study investigated the anticancer effects of two newly synthesized norcantharidin analogs, N-farnesyloxy-norcantharimide (NOC15) and N-farnesyl-norcantharimide (NC15), in L1210 cells and in a syngeneic mouse leukemia model (L1210 cell line plus DBA/2 mice). "
2.	Neoplasms (Cancer) 05/01/2020 - "To evaluate the anti-cancer mechanism of N-Farnesyl-norcantharimide (NC15). "

Related Drugs and Biologics

1.	norcantharidin
2.	N-farnesyloxy-norcantharimide